脓毒症患者CD8+ T细胞PD-1/CD28比值升高而非PD-1表达可预测医院获得性感染:一项前瞻性观察性队列研究
本研究为前瞻性观察性队列研究,在综合ICU纳入符合Sepsis-3标准的脓毒症患者,入组24小时内采集外周血,第1天检测CD8+ T细胞PD-1与CD28表达,随访至28天,最终68例纳入分析。22例(32.4%)发生医院获得性感染,其PD-1/CD28比值显著高于未感染组(0.27 vs 0.15,P=0.025);PD-1/CD28比值(OR 53.33,95%CI 2.39-1188.22,P=0.012)和机械通气时间(OR 1.14,95%CI 1.06-1.24,P=0.001)为医院获得性感染的独立相关因素,但比值预测医院获得性感染的AUC仅0.67(0.52-0.82)。19例(27.9%)28天内死亡,死亡者比值显著高于存活者(0.23 vs 0.14);比值≥0.13者生存时间更短(HR 4.42,95%CI 1.29-15.20,χ2=6.675,P=0.010)。作者认为入ICU时CD8+ T细胞PD-1/CD28比值可能作为预测医院获得性感染和死亡的新预后生物标志物。
要点
- 脓毒症患者入组第1天CD8+ T细胞PD-1/CD28比值≥0.13者28天生存时间更短(HR 4.42,95%CI 1.29-15.20,χ2=6.675,P=0.010)。
- 发生医院获得性感染者PD-1/CD28比值高于未感染者(0.27 vs 0.15,P=0.025),比值与机械通气时间均为独立相关因素(OR 53.33,P=0.012;OR 1.14,P=0.001)。
- PD-1/CD28比值预测医院获得性感染的AUC为0.67(0.52-0.82),判别能力有限。
- 死亡者PD-1/CD28比值高于存活者(0.23 vs 0.14),但原文未报告该比较的P值。
- 最终仅68例纳入分析,PD-1/CD28比值的OR置信区间极宽(2.39-1188.22),点估计不稳定。
适用人群与场景
- 综合ICU中符合Sepsis-3标准的脓毒症患者,入组24小时内采集外周血,第1天检测CD8+ T细胞PD-1与CD28表达,随访至28天。
- 共招募181例,最终68例纳入分析;原文未报告排除标准。
诊断标准与关键阈值
- 脓毒症诊断采用Sepsis-3标准。
- CD8+ T细胞PD-1/CD28比值≥0.13者28天生存时间更短(HR 4.42,95%CI 1.29-15.20,χ2=6.675,P=0.010)。
研究设计与关键结果
- 前瞻性观察性队列研究,在综合ICU进行,最终68例脓毒症患者纳入分析;19例(27.9%)28天内死亡,22例(32.4%)发生医院获得性感染。
- 发生医院获得性感染者CD8+ T细胞PD-1/CD28比值高于未感染者(0.27 [0.10-0.55] vs 0.15 [0.08-0.28],P=0.025)。
- 多因素回归显示CD8+ T细胞PD-1/CD28比值(OR 53.33,95%CI 2.39-1188.22,P=0.012)与机械通气时间(OR 1.14,95%CI 1.06-1.24,P=0.001)为医院获得性感染的独立相关因素。
- CD8+ T细胞PD-1/CD28比值预测医院获得性感染的AUC为0.67(0.52-0.82)。
- 死亡者CD8+ T细胞PD-1/CD28比值高于存活者(0.23 [0.15-0.52] vs 0.14 [0.07-0.32]),原文未报告该比较的P值;Cox回归显示比值≥0.13者生存时间更短(HR 4.42 [1.29-15.20],χ2=6.675,P=0.010)。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列研究;原文未标注证据等级。
- 局限:共招募181例,最终仅68例纳入分析;OR 95%CI 2.39-1188.22 极宽;AUC 0.67(0.52-0.82)提示判别能力有限;作者结论用「may serve as」,提示需进一步验证。
对床旁实践的改变
- 作者认为入ICU时CD8+ T细胞PD-1/CD28比值可能作为预测医院获得性感染和28天死亡的新预后生物标志物。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The expression of programmed cell death 1 receptor (PD-1) and CD28 on CD8+ T cells is considered to be related to immune function and prognosis markers in patients with sepsis. However, the relationship between the ratio of PD-1/CD28 and nosocomial infection has not been elucidated. Methods: A prospective, observational cohort study was conducted in a general intensive care unit. Patients were enrolled according to the sepsis-3 criteria and peripheral blood samples were collected within 24 hours of enrollment. Programmed cell death 1 receptor and CD28 expression on CD8+ T cells was assayed on day 1. Patients were followed up until 28 days. Multivariate regression analysis was used to assess independent risk factors for nosocomial infection. The accuracy of biomarkers for nosocomial infection and mortality was determined by the area under the receiver operating characteristic curve analysis. The association between biomarkers and 28-day mortality was assessed by Cox regression survival analysis. Results: A total of 181 patients were recruited, and 68 patients were finally included for analysis. Of these, 19 patients (27.9%) died during 28 days and 22 patients (32.4%) acquired nosocomial infection. The PD-1/CD28 ratio of patients with nosocomial infection was significantly higher than those without (0.27 [0.10-0.55] vs. 0.15 [0.08-0.28], P = 0.025). The PD-1/CD28 ratio in CD8+ T cells (odds ratio, 53.33; 95% confidence interval, 2.39-1188.22, P = 0.012) and duration of mechanical ventilation (odds ratio, 1.14; 95% confidence interval, 1.06-1.24; P = 0.001) were independently associated with nosocomial infection. The area under the receiver operating characteristic curve of PD-1/CD28 ratio in CD8+ T cells was 0.67 (0.52-0.82). The PD-1/CD28 ratio in CD8+ T cells of the nonsurvivors was significantly higher than the survivors (0.23 [0.15-0.52] vs. 0.14 [0.07-0.32]); Cox regression analysis showed that the survival time of patients with PD-1/CD28 ratio in CD8+ T cells of 0.13 or greater was shorter compared with patients with lower levels (hazard ratio, 4.42 [1.29-15.20], χ2 = 6.675; P = 0.010). Conclusions: PD-1/CD28 ratio in CD8+ T cells at admission may serve as a novel prognostic biomarker for predicting nosocomial infection and mortality.
参考来源
- Zhong W, Li J, Li D, et al. ELEVATED PD-1/CD28 RATIO RATHER THAN PD-1 EXPRESSION IN CD8+ T CELLS PREDICTS NOSOCOMIAL INFECTION IN SEPSIS PATIENTS: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY. Shock. 2022. PMID: 36166194. doi:10.1097/SHK.0000000000001967
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。